D L Carlson Investment Group Inc Abb Vie Inc. Transaction History

D L Carlson Investment Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 19, 2019	SELL	$65.7 - $83.98 $1.49 Million - $1.91 Million	-22,690 Closed	0 $0
Q1 2019 May 02, 2019	SELL	$77.14 - $90.79 $92,568 - $108,948	-1,200 Reduced 5.02%	22,690 $1.83 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $7,290 - $8,104	-82 Reduced 0.34%	23,890 $2.26 Million
Q2 2018 Aug 10, 2018	BUY	$89.78 - $106.23 $12,569 - $14,872	140 Added 0.59%	23,972 $2.22 Million
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $276,030 - $369,630	-3,000 Reduced 11.18%	23,832 $2.26 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $1.87 Million - $2.39 Million	26,832	26,832 $2.38 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of D L Carlson Investment Group Inc, based on Form 13F filings with the SEC.

Stay updated on D L Carlson Investment Group Inc with notifications on news.